Evaluation of incidence and risk factors for brachytherapy-induced Complications in uveal melanoma.

• Conditions: C69.3; H15.8; Choroid; Other disorders of sclera

• Registration Number: DRKS00019049
• Lead Sponsor: niversitätsklinikum Essen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 4900

Inclusion Criteria

Diagnosis: uveal melanoma
Therapy: brachytherapy
Time intervall: 1/1999-12/2016

Exclusion Criteria

Patients with uveal melanoma, managed with other therapieoptions like: primary enucleation or protom beam radiation

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess incidence and risk factors different brachytherapy-induced complications.

Secondary Outcome Measures

Name	Time	Method
Funkctional outcome, tumor control